Bright Path Laboratories, Inc

About:

Bright Path Labs patented advanced pharmaceutical manufacturing technology.

Website: http://brightpathlabs.com

Twitter/X: _BrightPathLabs

Description:

An agile and patented advanced pharmaceutical manufacturing technology paving the way for rapid, low-cost, and scalable domestic API production. Bright Path Labs (BPL) is positioned to immediately fill gaps in the drug supply chain in response to the COVID-19 pandemic and other potential treatments or subsequently discovered vaccines and medicines to address future health challenges. We have the physical and technical capacity for the agile research and development of advanced pharmaceutical manufacturing that is scalable, that helps us train a future workforce for research and is able to support Federal agencies to rapidly address drug shortages.

Total Funding Amount:

$8.46M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Kannapolis, North Carolina, United States

Founded Date:

2019-12-01

Contact Email:

tquinones(AT)brightpathlabs.com

Founders:

Phil Lichtenberger, Tony Quiñones

Number of Employees:

11-50

Last Funding Date:

2021-11-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai